戻る Agenda
Session 5: Combatting Misinformation about Medical Products
Session Chair(s)
Dale Cooke, JD, MA
President
FDA Ad Law, United States
Misinformation about medical products and healthcare more broadly presents a serious threat. This session will explore the nature of the threat, explain what is already being done by government, industry and technology platforms to address misinformation and look at specific actions companies can take when the misinformation addresses their products.
Learning Objective : At the conclusion of this session, participants should be able to:- Explain the threat posed by health misinformation Understand the actions taken by government, industry, and tech platforms to combat misinformation
- Identify means to combat misinformation about a company’s own products
Speaker(s)
Speaker
Heather Entenmann, MPH
Sanofi, United States
US Public Health Engagement Lead
Speaker
Marc Benjamin, MBA
Convergence Point Media, LLC, United States
CEO